Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study
- PMID: 21279504
- DOI: 10.1007/s00198-011-1537-x
Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study
Abstract
We evaluated the predictive ability of FRAX® in a cohort of 815 Japanese women. The observed 10-year fracture rate did not differ significantly from that predicted by FRAX®. The predictive ability of FRAX® without femoral neck bone mineral density (BMD) was similar to that with femoral neck BMD.
Introduction: We evaluated the ability of the Japanese version of FRAX®, a World Health Organization fracture risk assessment tool, to predict the 10-year probability of osteoporotic fracture.
Methods: Self-reported major osteoporotic fracture (N = 43) and hip fracture (N = 4) events were ascertained in the 10-year follow-up survey of the Japanese Population-Based Osteoporosis Cohort Study. Participants were 815 women aged 40-74 years at the baseline survey. Receiver operating characteristic curve analysis compared FRAX® with multiple logistic models based on age, body weight, and femoral neck BMD.
Results: The number of observed major osteoporotic or hip fracture events did not differ significantly from the number of events predicted by the FRAX® model (with or without BMD). The area under the curve (AUC) value for FRAX® with BMD for predicting major osteoporotic fractures was similar to that of a logistic model with age, body weight, and BMD (0.69 vs. 0.71, respectively; p = 0.198); the AUC of FRAX® with BMD for predicting hip fractures was similar to that of a model based on age and BMD (0.88 vs. 0.89, respectively; p = 0.164). The AUCs of FRAX® without BMD for predicting major osteoporotic and hip fractures were similar to those with BMD (0.69 vs. 0.67, respectively; p = 0.121; 0.88 vs. 0.86, respectively; p = 0.445).
Conclusions: The Japanese version of FRAX® without BMD estimated the 10-year probability of osteoporotic fracture in this population with few clinical risk factors as similar to that of FRAX® with BMD.
Similar articles
-
Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.BMC Musculoskelet Disord. 2016 Jun 17;17:262. doi: 10.1186/s12891-016-1096-6. BMC Musculoskelet Disord. 2016. PMID: 27317560 Free PMC article.
-
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.Osteoporos Int. 2011 Mar;22(3):829-37. doi: 10.1007/s00198-010-1465-1. Epub 2010 Dec 16. Osteoporos Int. 2011. PMID: 21161508 Free PMC article.
-
FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.BMC Musculoskelet Disord. 2012 Oct 22;13:204. doi: 10.1186/1471-2474-13-204. BMC Musculoskelet Disord. 2012. PMID: 23088223 Free PMC article. Clinical Trial.
-
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.Osteoporos Int. 2022 Oct;33(10):2103-2136. doi: 10.1007/s00198-022-06435-6. Epub 2022 May 31. Osteoporos Int. 2022. PMID: 35639106 Review.
-
Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions.Womens Health (Lond). 2024 Jan-Dec;20:17455057241231387. doi: 10.1177/17455057241231387. Womens Health (Lond). 2024. PMID: 38529935 Free PMC article. Review.
Cited by
-
The development and validation of a prediction model for imminent vertebral osteoporotic fracture in postmenopausal women.Eur Spine J. 2024 Jun 7. doi: 10.1007/s00586-024-08333-3. Online ahead of print. Eur Spine J. 2024. PMID: 38844587
-
Age-dependent FRAX-based assessment and intervention thresholds for therapeutic decision making in osteoporosis in the Malaysian population.Arch Osteoporos. 2024 Mar 20;19(1):18. doi: 10.1007/s11657-024-01371-w. Arch Osteoporos. 2024. PMID: 38503995
-
An enhanced version of FREM (Fracture Risk Evaluation Model) using national administrative health data: analysis protocol for development and validation of a multivariable prediction model.Diagn Progn Res. 2023 Oct 3;7(1):19. doi: 10.1186/s41512-023-00158-w. Diagn Progn Res. 2023. PMID: 37784165 Free PMC article.
-
Executive summary: Italian guidelines for diagnosis, risk stratification, and care continuity of fragility fractures 2021.Front Endocrinol (Lausanne). 2023 Apr 18;14:1137671. doi: 10.3389/fendo.2023.1137671. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37143730 Free PMC article.
-
A systematic review on the performance of fracture risk assessment tools: FRAX, DeFRA, FRA-HS.J Endocrinol Invest. 2023 Nov;46(11):2287-2297. doi: 10.1007/s40618-023-02082-8. Epub 2023 Apr 9. J Endocrinol Invest. 2023. PMID: 37031450 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
